小蘖鹼可能藉由 p185HER2/neu 蛋白質降解進而抑制神經膠原致癌基因過表現引起的細胞增生與轉移

Berberine may inhibit cell proliferation and metastasis via degradation of p185HER2/neu in HER2/neu-overexpressing cancer cells

林映妤(Ying-Yu Lin)

指導教授 ： 莊子超

淡江大學/理學院/化學學系碩士班/碩士(2008年)

https://doi.org/10.6846/TKU.2008.01224

摘要

本篇摘要未授權

關鍵字

小蘖鹼 ； 神經膠原致癌基因 ； 轉移

並列摘要

This abstract would not be displayed due to no authorization.

並列關鍵字

Berberine ； HER2/neu ； Metastasis

參考文獻

Abidi P, Zhou Y, Jiang JD and Liu J, 2005. Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine. Arterioscler. Thromb. Vasc. Biol. 25, 2170-2176

Allgayer H, Babic R, Gruetzner KU, Tarabichi A , Schildberg FW and Heiss MM, 2000. c-erbB-2 Is of Independent Prognostic Relevance in Gastric Cancer and Is Associated With the Expression of Tumor-Associated Protease Systems. Journal of Clinical Oncology 18(11), 2201-2209

Anis KV, Rajeshkumar NV and Kuttan R, 2001. Inhibition of chemical carcinogenesis by berberine in rats and mice. J Pharmacy Pharmacol 53(5), 763-768

Bando H, 2007. Vascular Endothelial Growth Factor and Bevacitumab inBreast Cancer. Breast Cancer 14(2), 163-173, Review

Ben-Av P, Crofford LJ, Wilder RL and Hla T, 1995. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372, 83-87